![Rico Buchli](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rico Buchli
Technik-/Wissenschafts-/F&E-Leiter bei Pure Protein LLC
Aktive Positionen von Rico Buchli
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Pure Protein LLC
![]() Pure Protein LLC Pharmaceuticals: MajorHealth Technology Pure Protein LLC specializes in immunology tools for diagnostics, drug and vaccine development, and high-yield protein production. It operates as a biopharmaceutical company, produces soluble human leukocyte antigen (sHLA) proteins and custom products in various human and animal cell lines. The firm provides sHLA class I and II proteins for use in transplantation, drug target discovery, and bio-therapeutic development, as well as diagnostic and therapeutic reagents for use in immunology research and development. The company was founded by William Hildebrand in 1999 and is headquartered in Austin, TX. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 | - |
University of Oklahoma | Corporate Officer/Principal | 29.07.2009 | - |
Karriereverlauf von Rico Buchli
Ausbildung von Rico Buchli
University of Basel | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Schweiz | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Pure Protein LLC
![]() Pure Protein LLC Pharmaceuticals: MajorHealth Technology Pure Protein LLC specializes in immunology tools for diagnostics, drug and vaccine development, and high-yield protein production. It operates as a biopharmaceutical company, produces soluble human leukocyte antigen (sHLA) proteins and custom products in various human and animal cell lines. The firm provides sHLA class I and II proteins for use in transplantation, drug target discovery, and bio-therapeutic development, as well as diagnostic and therapeutic reagents for use in immunology research and development. The company was founded by William Hildebrand in 1999 and is headquartered in Austin, TX. | Health Technology |
- Börse
- Insiders
- Rico Buchli
- Erfahrung